Prestige Consumer Healthcare Stock - Long-term demand and brand portfolio in focus
20.06.2026 - 18:32:58 | ad-hoc-news.de
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 18:31 CET. Details in the imprint.
Prestige Consumer Healthcare (US74116D1037) develops and markets branded over-the-counter health products in North America and selected international markets. With no new regulatory filings or major news today, the focus turns to how the company earns its money and where its stock currently stands in the consumer health landscape.
Background and data on Prestige Consumer Healthcare stock
Investors can track Prestige Consumer Healthcare's stock data, regulatory disclosures and corporate information via its topic page and the company's own investor relations site.
How the business is positioned
Prestige Consumer Healthcare focuses on over-the-counter health and personal care brands sold mainly through pharmacies, mass retailers and online channels. The company positions itself in categories such as digestive health, eye care, oral care and other everyday self-care segments.
This branded focus aims to capture relatively steady consumer demand, as many of its products address recurring needs like stomach discomfort, constipation or dry eyes. The firm typically markets products that consumers can buy without prescriptions, which can smooth revenue compared with more cyclical discretionary categories.
Long-term drivers and challenges
Demographic trends such as aging populations in the United States and other developed markets support long-term demand for self-care and OTC remedies. Consumers often prefer established brands they recognize, which can underpin pricing power and repeat purchases for companies with strong portfolios.
At the same time, Prestige Consumer Healthcare faces competition from other branded manufacturers and from private-label products offered by retailers. Retailers can push their own labels aggressively on price, so defending shelf space and brand loyalty remains a key management task over time.
The product behind the stock
One representative product in Prestige Consumer Healthcare's portfolio is the digestive health remedy line marketed under a well-known laxative brand. These products are positioned to provide predictable, gentle relief and are typically sold in tablet or liquid form across large pharmacy and grocery chains.
Where the stock trades today
The shares of Prestige Consumer Healthcare (US74116D1037) trade on the New York Stock Exchange around the mid-$40 range per share as of 06/20/2026, 18:31 CET.
Key facts on Prestige Consumer Healthcare stock
- Company: Prestige Consumer Healthcare Inc.
- ISIN: US74116D1037
- WKN: A12B3Z
- Ticker: PBH
- Venue: NYSE
- Price (as of 06/20/2026, 18:31 CET): approximately 46.99 USD
- Market cap: approximately 2.2 billion USD (as of mid-June 2026)
- Sector / Industry: Healthcare / Consumer Health, Over-the-Counter Products
- Index membership: not a member of major large-cap indices such as the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
